This application requests funding for the fourth competitive renewal of a postdoctoral training program in Cardiovascular Diseases. The program is designed to provide opportunities for Cardiology, Surgical and Pediatrics-based physician-scientist trainees to become independent investigators in Cardiovascular research. Trainees will be exposed to a diverse group of faculty, ranging from junior faculty to full-professor, each well-funded, with outstanding training and publication records. Trainees are encouraged to choose co-mentors, to enhance their multi-disciplinary training. Faculty mentors will direct research training in four primary areas: 1) Vascular Biology including atherosclerosis, diabetes and metabolism; 2) Cardiomyocyte biology, including ion channels, pharmacology and tissue- and biomedical-engineering, 3) Immunology and Genomics, and 4) Translational, Outcomes and Clinical Research. The usual duration of the program is two years but may be extended to three years. Candidates are selected from a very large pool of outstanding applicants to our clinical training programs in Surgery, Cardiothoracic Surgery, Adult and Pediatric Cardiology, Neonatology and Pediatric Critical Care, as well as through direct applications to the training program. Special efforts are undertaken to enhance our recruitment of woman and minorities, in part through affiliation with Harlem Hospital's Surgical Residency program. The training program and the core departments have well-established cardiovascular seminar series and journal clubs, joint laboratory meetings and retreats that are designed to foster collaborations and interdisciplinary research. In addition, the training program itself sponsors an annual retreat, seminars and monthly work-in-progress sessions to assess trainee progress. The training program has an efficient evaluation and feedback system to ensure appropriate training of our fellows. Throughout the program and afterwards, trainees are advised on research and career development, individually and through a mentoring program headed by an Associate Director for Trainee Development. The program is designed to take advantage of the many existing strengths of Columbia University, including the Irving Center for Clinical and Translational Research (CTSA), Mailman School of Public Health, Genome Center, Bioinformatics, Tissue and Biomedical Engineering and numerous basic science departments and strong clinical programs, as well as the established track record of research training of physician-scientists in this program for the past 20 years.

Public Health Relevance

Our training program seeks to train physicians and surgeons in the design and execution of high-quality clinically relevant cardiovascular research. The program is designed to enhance and ensure the development of academic leaders by acquiring broad-based scientific knowledge. Highly qualified applicants, with an excellent representation of minorities and women, have filled all slots within the training program.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007854-21
Application #
8998638
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Carlson, Drew E
Project Start
1996-07-01
Project End
2021-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
21
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Surgery
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Anstey, D Edmund; Colantonio, Lisandro D; Yano, Yuichiro et al. (2018) The importance of using 24-hour and nighttime blood pressure for the identification of white coat hypertension: Data from the Jackson Heart Study. J Clin Hypertens (Greenwich) :
Bikdeli, Behnood; Sharif-Kashani, Babak; Bikdeli, Bavand et al. (2018) Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis. Semin Thromb Hemost 44:341-347
Chatterjee, Debanjana; Moore, Carolina; Gao, Baoshan et al. (2018) Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy. J Heart Lung Transplant 37:385-393
Guenthart, Brandon A; O'Neill, John D; Kim, Jinho et al. (2018) Cell replacement in human lung bioengineering. J Heart Lung Transplant :
Rosen, Sarah J; Harris, Paul E; Hardy, Mark A (2018) State of the Art: Role of the Dendritic Cell in Induction of Allograft Tolerance. Transplantation 102:1603-1613
Chaudhry, S G; Bentley-Hibbert, S; Stern, J et al. (2018) Growth of liver allografts over time in pediatric transplant recipients. Pediatr Transplant 22:
Clerkin, Kevin J; Farr, Maryjane A; Mancini, Donna M (2018) Letter by Clerkin et al Regarding Article, ""Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation"". Circulation 137:1870-1871
Bikdeli, Behnood; Stone, Gregg W (2018) Bivalirudin bewilderment. Kardiol Pol 76:711-712
Bromfield, Samantha G; Booth 3rd, John N; Loop, Matthew S et al. (2018) Evaluating different criteria for defining a complete ambulatory blood pressure monitoring recording: data from the Jackson Heart Study. Blood Press Monit 23:103-111
Bikdeli, Behnood; Jimenez, David; Hawkins, Mayra et al. (2018) Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE). Thromb Haemost 118:214-224

Showing the most recent 10 out of 224 publications